NCT04257448
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04257448
Title Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer (SEPION)
Acronym SEPION
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GWT-TUD GmbH
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Uniklinik Köln Cologne 50937 Germany Details
Universitätsklinikum Essen Essen 45147 Germany Details
Universitätsklinikum Frankfurt Frankfurt 60590 Germany Details
Universitätsmedizin Göttingen Göttingen 37075 Germany Details
Universitätsklinikum Hamburg-Eppendorf Hamburg 20251 Germany Details
Ludwig-Maximilians-Universität München München 81377 Germany Details
Klinikum Nürnberg Nuremberg 90419 Germany Details
Universitätsklinikum Ulm Ulm 89081 Germany Details
Universitätsklinikum Würzburg Würzburg 97080 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field